Published in Drug Law Weekly, April 1st, 2008
"To our knowledge, the anatomic proximity of the two tumors at the level of kidneys has not been previously described. Because of the patient's other medical conditions, systemic chemotherapy was not deemed feasible," wrote C.A. Dasanu and colleagues.
The researchers concluded: "Subsequently, the proliferation had a favorable response to single-agent monoclonal antibody rituximab."
Dasanu and colleagues published their study in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-04-01)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.